Epizyme Inc (EPZM)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: EPZM Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-04-13 2022-04-11 PS Planned sale

Kutok Jeffery

Chief Scientific Officer

Officer
2,741 -2.8%
0.90
2,467 USD 		2,741 -2.8% 0.90 2,467 USD
2022-02-09 2022-02-07 PS Planned sale

Agarwal Shefali

See Remarks

Officer
1,058 -0.7%
1.50
1,587 USD 		1,058 -0.7% 1.50 1,587 USD
2022-02-09 2022-02-07 PS Planned sale

Beaulieu Joseph

Corporate Controller

Officer
222 -0.8%
1.50
333 USD 		222 -0.8% 1.50 333 USD
2022-02-04 2022-02-02 PS Planned sale

Agarwal Shefali

See Remarks

Officer
2,639 -1.6%
1.37
3,615 USD 		2,639 -1.6% 1.37 3,615 USD
2022-02-04 2022-02-02 PS Planned sale

Beaulieu Joseph

Corporate Controller

Officer
687 -2.3%
1.37
941 USD 		687 -2.3% 1.37 941 USD
2022-02-04 2022-02-02 PS Planned sale

Kutok Jeffery

Chief Scientific Officer

Officer
2,556 -2.6%
1.37
3,502 USD 		2,556 -2.6% 1.37 3,502 USD
2022-02-01 2022-01-31 B Purchase

Legorreta Pablo G.

Non-Executive Director Major owner
22,666,667 +247.3%
1.50
34,000,001 USD 		22,666,667 +247.3% 1.50 34,000,001 USD
2022-01-28 2022-01-26 PS Planned sale

Agarwal Shefali

See Remarks

Officer
2,922 -1.8%
2.02
5,902 USD 		2,922 -1.8% 2.02 5,902 USD
2021-12-07 2021-12-06 PS Planned sale

Agarwal Shefali

See Remarks

Officer
1,780 -1.1%
2.93
5,215 USD 		1,780 -1.1% 2.93 5,215 USD
2021-03-29 2021-03-26 B Purchase

MOTT DAVID M

Non-Executive Director
217 +0.1%
7.80
1,693 USD 		217 +0.1% 7.80 1,693 USD
2021-03-29 2021-03-26 B Purchase

MOTT DAVID M

Non-Executive Director
34,269 +29.4%
7.97
273,124 USD 		34,269 +29.4% 7.97 273,124 USD
2021-03-29 2021-03-25 PS Planned sale

Bazemore Robert B

President & CEO

Executive Director
10,328 -3.1%
7.85
81,075 USD 		10,328 -3.1% 7.85 81,075 USD
2021-03-29 2021-03-25 B Purchase

MOTT DAVID M

Non-Executive Director
28,231 +32.0%
7.98
225,283 USD 		28,231 +32.0% 7.98 225,283 USD
2021-02-05 2021-02-04 PS Planned sale

Beaulieu Joseph

Corporate Controller

Officer
227 -1.7%
11.21
2,545 USD 		227 -1.7% 11.21 2,545 USD
2021-02-05 2021-02-04 PS Planned sale

Ros Matthew

See Remarks

Officer
894 -1.1%
11.21
10,022 USD 		894 -1.1% 11.21 10,022 USD
2021-02-05 2021-02-04 PS Planned sale

Agarwal Shefali

Chief Medical Officer

Officer
969 -0.9%
11.21
10,862 USD 		969 -0.9% 11.21 10,862 USD
2021-02-05 2021-02-04 PS Planned sale

TOMBESI PAOLO

Chief Financial Officer

Officer
1,021 -1.9%
11.21
11,445 USD 		1,021 -1.9% 11.21 11,445 USD
2021-02-05 2021-02-04 PS Planned sale

Bazemore Robert B

President & CEO

Executive Director
3,890 -1.2%
11.21
43,607 USD 		3,890 -1.2% 11.21 43,607 USD
2021-02-05 2021-02-04 PS Planned sale

Vakiener Victoria

Chief Commercial Officer

Officer
817 -1.5%
11.21
9,159 USD 		817 -1.5% 11.21 9,159 USD
2021-01-27 2021-01-25 PS Planned sale

Ros Matthew

See Remarks

Officer
2,872 -4.9%
11.41
32,770 USD 		2,872 -4.9% 11.41 32,770 USD
2021-01-27 2021-01-25 PS Planned sale

Bazemore Robert B

President & CEO

Executive Director
6,069 -2.4%
11.41
69,247 USD 		6,069 -2.4% 11.41 69,247 USD
2021-01-27 2021-01-25 PS Planned sale

Agarwal Shefali

Chief Medical Officer

Officer
2,872 -3.7%
11.41
32,770 USD 		2,872 -3.7% 11.41 32,770 USD
2021-01-27 2021-01-25 PS Planned sale

Vakiener Victoria

Chief Commercial Officer

Officer
599 -2.1%
11.41
6,835 USD 		599 -2.1% 11.41 6,835 USD
2020-12-07 2020-12-03 PS Planned sale

Agarwal Shefali

Chief Medical Officer

Officer
2,522 -3.2%
13.54
34,148 USD 		2,522 -3.2% 13.54 34,148 USD
2020-11-13 2020-11-11 B Purchase

GOLDFISCHER CARL

Non-Executive Director
5,000 +inf%
12.07
60,350 USD 		5,000 +inf% 12.07 60,350 USD
2020-09-03 2020-09-02 PS Planned sale

Beaulieu Joseph

Corporate Controller

Officer
543 -8.4%
12.88
6,994 USD 		543 -8.4% 12.88 6,994 USD
2020-06-26 2020-06-26 B Purchase

MOTT DAVID M

Non-Executive Director
62,019 +301.3%
16.03
994,165 USD 		62,019 +301.3% 16.03 994,165 USD
2020-06-22 2020-06-18 PS Planned sale

Ros Matthew

See Remarks

Officer
68,651 -57.0%
21.65
1,486,294 USD 		68,651 -57.0% 21.65 1,486,294 USD
2020-06-22 2020-06-18 PS Planned sale

Ros Matthew

See Remarks

Officer
2,289 -4.2%
22.00
50,358 USD 		2,289 -4.2% 22.00 50,358 USD
2020-06-22 2020-06-18 PS Planned sale

Ros Matthew

See Remarks

Officer
41,063 -44.2%
20.50
841,792 USD 		41,063 -44.2% 20.50 841,792 USD
2020-06-22 2020-06-18 S Sale

Bazemore Robert B

President & CEO

Executive Director
10,000 -3.9%
22.00
220,000 USD 		10,000 -3.9% 22.00 220,000 USD
2020-06-22 2020-06-18 S Sale

Bazemore Robert B

President & CEO

Executive Director
10,000 -3.8%
22.00
220,000 USD 		10,000 -3.8% 22.00 220,000 USD
2020-03-26 2020-03-25 PS Planned sale

Beaulieu Joseph

Corporate Controller

Officer
212 -4.1%
15.28
3,239 USD 		212 -4.1% 15.28 3,239 USD
2020-03-26 2020-03-25 PS Planned sale

Agarwal Shefali

Chief Medical Officer

Officer
1,243 -1.7%
15.28
18,993 USD 		1,243 -1.7% 15.28 18,993 USD
2020-03-26 2020-03-25 PS Planned sale

Ros Matthew

See Remarks

Officer
1,243 -2.3%
15.28
18,993 USD 		1,243 -2.3% 15.28 18,993 USD
2020-03-26 2020-03-25 PS Planned sale

TOMBESI PAOLO

Chief Financial Officer

Officer
1,243 -7.5%
15.28
18,993 USD 		1,243 -7.5% 15.28 18,993 USD
2020-03-26 2020-03-25 PS Planned sale

Bazemore Robert B

President & CEO

Executive Director
3,285 -1.3%
15.28
50,195 USD 		3,285 -1.3% 15.28 50,195 USD
2020-03-05 2020-03-03 PS Planned sale

Beaulieu Joseph

Corporate Controller

Officer
996 -21.6%
22.18
22,091 USD 		996 -21.6% 22.18 22,091 USD
2020-01-27 2020-01-27 PS Planned sale

Bazemore Robert B

President & CEO

Executive Director
6,074 -6.7%
20.44
124,153 USD 		6,074 -6.7% 20.44 124,153 USD
2020-01-27 2020-01-27 PS Planned sale

Agarwal Shefali

Chief Medical Officer
2,630 -4.3%
20.44
53,757 USD 		2,630 -4.3% 20.44 53,757 USD
2020-01-27 2020-01-24 PS Planned sale

Bazemore Robert B

President & CEO

Executive Director
3,002 -3.2%
24.62
73,909 USD 		3,002 -3.2% 24.62 73,909 USD
2020-01-27 2020-01-24 PS Planned sale

Ros Matthew

See Remarks
1,847 -4.2%
24.64
45,510 USD 		1,847 -4.2% 24.64 45,510 USD
2020-01-27 2020-01-24 PS Planned sale

Beaulieu Joseph

Corporate Controller
330 -24.1%
24.63
8,128 USD 		330 -24.1% 24.63 8,128 USD
2020-01-27 2020-01-24 PS Planned sale

Agarwal Shefali

Chief Medical Officer
1,843 -2.9%
24.64
45,412 USD 		1,843 -2.9% 24.64 45,412 USD
2020-09-03 2019-09-03 PS Planned sale

Beaulieu Joseph

Corporate Controller

Officer
971 -13.0%
12.77
12,400 USD 		971 -13.0% 12.77 12,400 USD
2019-06-28 2019-06-27 S Sale

MOTT DAVID M

52,473 -100.0%
12.43
652,134 USD 		52,473 -100.0% 12.43 652,134 USD
2019-06-26 2019-06-26 S Sale

MOTT DAVID M

52,472 -50.0%
12.85
674,176 USD 		52,472 -50.0% 12.85 674,176 USD
2019-06-26 2019-06-25 S Sale

MOTT DAVID M

52,472 -33.3%
13.31
698,649 USD 		52,472 -33.3% 13.31 698,649 USD
2019-06-17 2019-06-14 PS Planned sale

Agarwal Shefali

Chief Medical Officer
1,195 -3.2%
11.97
14,304 USD 		1,195 -3.2% 11.97 14,304 USD
2019-06-14 2019-06-13 PS Planned sale

Bazemore Robert B

President & CEO

Executive Director
2,074 -2.4%
12.10
25,095 USD 		2,074 -2.4% 12.10 25,095 USD
2019-06-14 2019-06-13 PS Planned sale

Ros Matthew

See Remarks
1,185 -2.9%
12.10
14,339 USD 		1,185 -2.9% 12.10 14,339 USD
2019-06-14 2019-06-13 PS Planned sale

Beaulieu Joseph

Corporate Controller
203 -29.0%
12.10
2,456 USD 		203 -29.0% 12.10 2,456 USD
2018-10-05 2018-10-05 B Purchase

MOTT DAVID M

Non-Executive Director
416,667 +6.9%
9.00
3,750,003 USD 		416,667 +6.9% 9.00 3,750,003 USD
2018-02-06 2018-02-05 S Sale

Ros Matthew

Chief Operating Officer

Officer
519 -16.6%
17.20
8,927 USD 		519 -16.6% 17.20 8,927 USD
2018-02-06 2018-02-05 S Sale

Ros Matthew

Chief Operating Officer

Officer
71,745 -95.8%
16.63
1,192,768 USD 		71,745 -95.8% 16.63 1,192,768 USD
2017-10-25 2017-10-24 S Sale

Ho Peter Tai-Ching

Chief Development Officer
15,000 -64.9%
16.44
246,591 USD 		15,000 -64.9% 16.44 246,591 USD
2017-09-26 2017-09-25 S Sale

Ho Peter Tai-Ching

Chief Development Officer
15,000 -64.9%
16.81
252,077 USD 		15,000 -64.9% 16.81 252,077 USD
2017-09-18 2017-09-18 B Purchase

MOTT DAVID M

200,000 +3.4%
15.25
3,050,000 USD 		200,000 +3.4% 15.25 3,050,000 USD
2017-08-28 2017-08-24 S Sale

Ho Peter Tai-Ching

Chief Development Officer
15,000 -67.5%
15.68
235,266 USD 		15,000 -67.5% 15.68 235,266 USD
2017-07-26 2017-07-24 S Sale

Ho Peter Tai-Ching

Chief Development Officer

Officer
15,000 -67.5%
13.44
201,572 USD 		15,000 -67.5% 13.44 201,572 USD
2017-07-05 2017-06-30 PS Planned sale

Singer Andrew E.

EVP & CFO

Officer
3,024 -6.9%
15.50
46,872 USD 		3,024 -6.9% 15.50 46,872 USD
2017-06-27 2017-06-26 S Sale

Ho Peter Tai-Ching

Chief Development Officer
15,000 -67.5%
14.87
223,115 USD 		15,000 -67.5% 14.87 223,115 USD
2017-06-07 2017-06-06 S Sale

Copeland Robert A

President of Research and CSO
2,500 -7.3%
13.45
33,625 USD 		2,500 -7.3% 13.45 33,625 USD
2017-05-26 2017-05-25 S Sale

Ho Peter Tai-Ching

Chief Development Officer

Officer
15,000 -67.5%
16.11
241,664 USD 		15,000 -67.5% 16.11 241,664 USD
2017-05-03 2017-05-02 S Sale

Copeland Robert A

President of Research and CSO

Officer
5,000 -13.7%
17.44
87,213 USD 		5,000 -13.7% 17.44 87,213 USD
2017-04-05 2017-04-04 S Sale

Copeland Robert A

President of Research and CSO
2,500 -7.3%
16.36
40,896 USD 		2,500 -7.3% 16.36 40,896 USD
2017-04-05 2017-04-04 S Sale

Copeland Robert A

President of Research and CSO
2,500 -6.8%
16.36
40,909 USD 		2,500 -6.8% 16.36 40,909 USD
2017-04-03 2017-03-31 PS Planned sale

Singer Andrew E.

EVP & CFO
2,013 -5.3%
17.09
34,394 USD 		2,013 -5.3% 17.09 34,394 USD
2017-01-10 2017-01-09 PS Planned sale

Singer Andrew E.

EVP & CFO
1,013 -3.0%
12.04
12,194 USD 		1,013 -3.0% 12.04 12,194 USD
2016-12-12 2016-12-09 PS Planned sale

Singer Andrew E.

EVP & CFO

Officer
1,013 -3.1%
11.03
11,172 USD 		1,013 -3.1% 11.03 11,172 USD
2016-12-12 2016-12-08 S Sale

Ho Peter Tai-Ching

Chief Development Officer

Officer
200 -3.5%
10.89
2,179 USD 		200 -3.5% 10.89 2,179 USD
2016-11-10 2016-11-09 PS Planned sale

Singer Andrew E.

EVP & CFO

Officer
1,013 -3.2%
10.40
10,535 USD 		1,013 -3.2% 10.40 10,535 USD
2016-10-12 2016-10-10 PS Planned sale

Singer Andrew E.

EVP & CFO

Officer
1,013 -3.4%
9.72
9,848 USD 		1,013 -3.4% 9.72 9,848 USD
2016-09-12 2016-09-09 PS Planned sale

Singer Andrew E.

EVP & CFO

Officer
1,013 -3.6%
7.55
7,651 USD 		1,013 -3.6% 7.55 7,651 USD
2016-08-10 2016-08-09 PS Planned sale

Singer Andrew E.

EVP & CFO

Officer
1,013 -3.7%
9.05
9,166 USD 		1,013 -3.7% 9.05 9,166 USD